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The impact of body mass index on perioperative
outcomes of open and endovascular abdominal
aortic aneurysm repair from the National Surgical
Quality Improvement Program, 2005-2007
Kristina A. Giles, MD, Mark C. Wyers, MD, Frank B. Pomposelli, MD, Allen D. Hamdan, MD,
Y. Avery Ching, MD, and Marc L. Schermerhorn, MD, Boston, Mass
Objectives: Obesity and morbid obesity have been shown to increase wound infections and occasionally mortality after
many surgical procedures. Little is known about the relative impact of body mass index (BMI) on these outcomes after
open (OAR) and endovascular abdominal aortic aneurysm repair (EVAR).
Methods: The 2005-2007 National Surgical Quality Improvement Program (NSQIP), a multi-institutional risk-adjusted
database, was retrospectively queried to compare perioperative mortality (in-hospital or 30-day) and postoperative
wound infections after OAR and EVAR. Patient demographics, comorbidities, and operative details were analyzed.
Obesity was defined as a BMI>30 kg/m2 andmorbid obesity as a BMI>40 kg/m2. Outcomes were compared with t test,
Wilcoxon rank sum, 2, and multivariate logistic regression.
Results: There were 2097 OARs and 3358 EVARs. Compared with EVAR, OAR patients were younger, more likely to be
women (26% vs 17%, P< .001), and less obese (27% vs 32%, P< .001).Mortality was 3.7% after OAR vs 1.2% after EVAR
(risk ratio, 3.1; P < .001), and overall morbidity was 28% vs 12%, respectively (relative risk, 2.3; P < .001). Morbidly
obese patients had a higher mortality for both OAR (7.3%) and EVAR (2.4%) than obese patients (3.9% OAR; 1.5%
EVAR) or nonobese patients (3.7% OAR; 1.1% EVAR). Obese patients had a higher rate of wound infection vs nonobese
after OAR (6.3% vs 2.4%, P< .001) and EVAR (3.3% vs 1.5%, P< .001). Morbid obesity predicted death after OAR but
not after EVAR, and obesity was an independent predictor of wound infection after OAR and EVAR.
Conclusions:Morbid obesity confers a worse outcome for death after abdominal aortic aneurysm repair. Obesity is also a
risk factor for infectious complications after OAR and EVAR. Obese patients and, particularly, morbidly obese patients
should be treated with EVAR when anatomically feasible. ( J Vasc Surg 2010;52:1471-7.)As the obesity epidemic in the United States continues
to grow, the effect that this may have upon medical out-
comes must be considered.1 Obesity has been associated
with increased prevalence of morbidity and infectious com-
plications after cardiac and general surgical operations;
however, the effect of obesity or bodymass index (BMI) on
perioperative mortality is less definitive.2-5 A few studies
have shown a significant increase in mortality in obese
patients, but many large studies have failed to find signifi-
cant relationships.2-5 In fact, being underweight, but not
overweight, has been associated with increased mortality in
some studies.5
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doi:10.1016/j.jvs.2010.07.013The effect of BMI on vascular procedures is even less
well known.6-10 In lower extremity bypass, obesity has been
associated with greater wound complications but not mor-
tality.6,7 With the increasing use of endovascular tech-
niques, there is a question of how obesity affects morbidity
and mortality with both open vascular and endovascular
procedures. Endovascular aneurysm repair (EVAR) of ab-
dominal aortic aneurysm (AAA), compared with its open
surgical (OAR) counterpart, avoids a large retroperitoneal
or transperitoneal incision. The groin incisions required to
expose the femoral arteries for EVAR are even being re-
placed by totally percutaneous techniques in many pa-
tients.11,12 Wound complications may be reduced with this
trend toward smaller incisions, but even percutaneous ac-
cess has been found to have higher complication rates in
morbid obesity.11 Obesity may also result in increased
wound infections regardless of repair method.
Most large databases do not include adequate informa-
tion to evaluate obesity as a predictor for morbidity or
mortality. The American College of Surgeons National
Surgical Quality Improvement Program (NSQIP), how-
ever, contains height and weight variables as well as detailed
30-day outcomes, including wound infections and a num-
ber of other postoperative complications, which make it
ideally suited for this purpose.13 We used the NSQIP
database to assess the effect of BMI on perioperative mor-
tality and morbidity with specific attention to surgical site
infections after OAR and EVAR.
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Database. We reviewed the data within the NSQIP
database from 2005-2007. This database is a national,
prospective, risk-adjusted database including data from
200 participating community and academic medical cen-
ters throughout the United States.12 Commensurate with
each center’s overall case volume, all or a randomly selected
proportion of procedures are prospectively selected for
analysis. Trained clinical nurses review prospectively re-
corded data and patient information. A comprehensive list
of preoperative comorbidities are collected, along with
operative and perioperative variables and the primary sur-
geon’s specialty. The 30-day postoperative outcomes are
collected, including hospital course, rehospitalization and
reoperation data, postoperative clinic visits, and follow-up
phone contact.
Data analysis. The NSQIP database was queried us-
ing SAS 9.1 statistical software (SAS Institute Inc, Cary,
NC) for elective OAR and EVAR as identified by Current
Procedural Terminology, 4th edition (CPT-4) procedural
coding combined with International Classification of Dis-
eases, 9th edition (ICD-9) diagnosis coding. Ruptured an-
eurysms, thoracic and thoracoabdominal aneurysms, and
aortic dissections were excluded. Patients unresponsive on
the initial hospital arrival or those requiring mechanical
ventilation48 hours before surgery were excluded for the
purposes of this study because they may have represented
incorrectly identified ruptured aneurysms. The analysis also
excluded patients undergoing open conversion after at-
tempted EVAR.
Preoperative demographic and comorbidity variables
were recorded for each patient. Weight classification was
assigned based on BMI (kg/m2) and the National Insti-
tutes ofHealth definitions of underweight (18.6 kg/m2),
normal weight (18.7-25 kg/m2), overweight (25.1-30 kg/
m2), obese class I (30.1-35 kg/m2), obese class II (35.1-40
kg/m2), and obese class III (40 kg/m2). Obesity overall
includes obese class I through III, and the subset of obese
class III was often considered separately and referred to as
morbid obesity. Renal disease was defined as hemodialysis
dependence or a preoperative concentration of serum cre-
atinine 1.8 mg/dL. Angina and congestive heart failure
comorbidity definitions required active symptoms 30
days before admission.
Intraoperative outcome variables included blood trans-
fusion volume (units), operative time (hours), and intraop-
erative complications (cardiac arrest, myocardial infarction,
or unplanned intubation). Thirty-day postoperative events
included death, surgical site infection (superficial, deep, or
organ space infection), wound dehiscence, graft failure,
subsequent major operation, and 13 other NSQIP-defined
complications. Graft failure was defined by NSQIP as “me-
chanical graft failure requiring return to the operating
room, interventional radiology, or balloon angioplasty.”
Hospital length of stay was also measured.
Statistical analysis. Statistical analysis was performed
using STATA statistical software (StataCorp LP, CollegeStation, Tex). Statistical significance was defined as P.05.
Demographics, comorbidities, and perioperative events
and outcomes were compared between OAR and EVAR
cohorts. Categoric variables were analyzed using 2 or
Fisher exact tests, and continuous variables were compared
using the t test for parametric data or the Wilcoxon rank
sum test for nonparametric data. Preoperative predictors of
wound infection, overall morbidity, and mortality were
analyzed by univariate and multivariate logistic regression
with backwards selection. For postoperative events, a uni-
variate analysis of mortality was performed. Odds ratios
(OR) are presented with 95% confidence intervals (CI).
RESULTS
Within the time period, 2097 OARs (38.4%) and 3358
EVARs (61.6%) were performed. The proportion of EVAR
increased from 57.6% in 2005 to 64.2% in 2007. Vascular
surgeons performed 97% of the EVAR and OAR proce-
dures.
Demographics and comorbidities. Patient variables
are detailed in Table I. Compared with OAR, the EVAR
group was older, included significantly more octogenari-
ans, and was more frequently male. Race/ethnicity was
equivalent between the groups. The EVAR patients had
higher rates of congestive heart failure, diabetes mellitus,
obesity class I and II, and long-term steroid use. The OAR
patients had higher rates of hypertension, rest pain or
gangrene, current smoking, and significant alcohol use.
When the distribution of BMI was compared by repair
method (Fig 1), obese class I and class II patients were
more likely to undergo EVAR than OAR. OAR was used
more frequently in underweight, normal weight, over-
weight, and morbidly obese patients, although the differ-
ences lacked statistical significance. There were no differ-
ences in preoperative incidences of wound infection or
sepsis (Table I).
Intraoperative variables. General anesthesia was used
in 98% of OAR cases but in only 77% of EVAR cases (P 
.001). Median operative times (3.6 vs 2.5 hours, P .001)
and blood transfusion requirements (2 vs 0 U, P  .001)
were higher for OAR than for EVAR. Intraoperative com-
plications were rare in both repairs (0.5% vs 0.3%, P .40).
Mortality rates. Mortality was 3.7% after OAR and
1.2% after EVAR (P  .001). Overall AAA mortality for
both repair types combined showed a U-shaped distribu-
tion (Fig 2, A). There was a higher mortality at the ex-
tremes of weight, underweight (3.7%), and morbidly obese
patients (4.3%) compared with the remaining weight clas-
sifications, which had a combined mortality of 2.1% (P 
.01 and P  .01). A comparison of OAR and EVAR
individually by weight class showed mortality after OAR
was nearly twice as high in morbidly obese patients (7.3%)
than in other OAR weight categories (P  .08) and nearly
three times as high as similarly obese EVAR patients (P 
.09), although not statistically significant (Fig 2, B). For
underweight OAR patients, the effect of BMI 18 kg/m2
was not as apparent, with mortality comparable to the OAR
group as a whole (3.6% vs 3.7%, P  .95). The highest
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underweight population, and was more than three times
the overall EVAR risk, P  .05), whereas the morbidly
Table I. Baseline characteristics of patients undergoing
endovascular (EVAR) or open repair (OAR) of
abdominal aortic aneurysms in 2005-2007
Variable
OAR EVAR
P(n  2097 (n 3358)
Age, mean  SD, year 71.5  8.5 74.1  8.4 .001
Age groups, year %
60 10.0 6.5 .001
61-70 32.8 24.9 .001
71-80 43.6 44.4 .56
80 13.6 24.2 .001
Female, % 26.2 17.2 .001
Black or other race (vs white), % 7.0 7.4 .55
Admission from
Home, % 96.5 98.3 .001
Acute care, % 3.5 1.7 .001
Comorbidities, %
Obese 27.1 31.7 .001
Weight class by BMI (kg/m2)
Underweight (18.6) 2.7 2.4 .51
Normal weight (18.6-25) 29.4 27.4 .11
Overweight (25-30) 40.8 38.5 .09
Obese I (30-35) 17.9 21.1 .01
Obese II (35-40) 5.3 6.9 .05
Morbid obesity (40) 3.9 3.8 .84
Renal disease 9.3 8.6 .36
Dialysis-dependent ESRD 0.6 1.0 .12
Chronic renal insufficiencya 9.3 8.5 .33
Cardiac disease 39.0 40.9 .17
Previous cardiac surgery 24.9 25.4 .66
Previous PCI 19.5 20.2 .53
Prior myocardial infarction
(6 months) 1.7 1.2 .21
Angina 30 days 2.2 2.2 .98
Congestive heart failure 30
days 0.8 1.4 .05
Prior surgery for PVDb 5.6 5.6 .92
PVD with rest pain or tissue loss 1.8 0.9 .01
Cerebrovascular disease 14.9 14.6 .78
Hypertension 83.3 78.5 .001
Diabetes mellitus (oral Rx or
insulin) 11.5 14.4 .01
Insulin controlled 1.9 2.6 .12
Oral medication controlled 9.6 11.8 .01
COPD 18.4 19.0 .58
Long-term steroid use 3.1 4.1 .05
Weight loss 10 within 6
months 2.3 2.0 .46
Poor functional status pre-op 4.8 4.3 .42
Current smoker ( 1 y) 41.5 28.7 .001
Alcohol (2 drinks/d past
2 weeks) 5.4 4.2 .05
Pre-op transfusion 4 U 0.05 0.03 .74
Pre-op wound 1.2 1.2 .96
Pre-op acute renal failure 0.2 0.2 .87
Sepsis 2.2 1.6 .12
BMI, Body mass index;COPD, chronic obstructive pulmonary disease;DM,
diabetes mellitus; ESRD, end-stage renal disease;MI,myocardial infarction;
PCI, percutaneous cardiac intervention; PVD, peripheral vascular disease.
aCreatinine 1.8 mg/dL.
bPercutaneous transluminal angioplasty or stenting, bypass graft, or amputation.obese group, at 2.4%, also had a trend of higher mortality oftwo times the overall EVAR risk (P  .20). For all weight
classifications other than underweight, mortality after
EVAR was less than half of the mortality after OAR (Fig 2,
A). For underweight EVAR patients this EVAR mortality
benefit was negated, with similar mortality rates to OAR
(3.6% OAR vs 3.8% EVAR, P  .95).
Morbidity. Overall morbidity was 28% after OAR and
12% after EVAR (P  .001). The most frequent complica-
tions were subsequent major operation, pneumonia, rein-
tubation, and septic shock. Subsequent major operations
30 days were performed in 8% of OAR patients and in 5%
Fig 1. Weight class categorization by body mass index (BMI) of
patients undergoing endovascular (EVAR) or open repair of ab-
dominal aortic aneurysms in 2005-2007.
Fig 2. Mortality by bodymass index classification for (A) patients
undergoing endovascular (EVAR) vs open repair of abdominal
aortic aneurysms (AAA) in 2005-2007 and (B) for all AAA.of EVAR patients (P  .001). Graft failure with need for
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to graft failure of 5.2 days after OAR vs 8.5 days after EVAR
(P  .05). EVAR morbidity across weight classifications
showed slightly higher rates at the extremes of weight strata
(P  .05 overall), with the most significant difference in
underweight patients (21.5% vs 11.9%, P  .01). OAR
morbidity was highest in the underweight category (43%,
P  .05) and similar amongst the remaining BMI classes
(Fig 3). Obese and nonobese patients had a similar rate of
morbidity (19% vs 18%, P  .48).
As a subset of morbidity, surgical site infections oc-
curred in 4% ofOAR patients and in 2% of EVAR (P .01).
Obese (class I, II, and morbidly obese) patients had an
increased prevalence of surgical site infections for all AAA
repair (4.4% vs 1.9%, P .001) as well as for the subsets of
OAR (6.3% vs 2.4%, P  .001) and EVAR (3.3% vs 1.5%,
P .001). There was an increasing prevalence of surgical site
infections with increasing BMI in OAR patients (Fig 4).
For all AAA repair, surgical site infections were associated
with a longer median length of stay (7 vs 4 days, P .001),
a greater likelihood of subsequent major operation (32% vs
5%, P  .001), and a higher rate of graft failure (8% vs 1%,
P .001). Surgical site infections were also associated with
Fig 3. Morbidity by body mass index classification for patients
undergoing endovascular (EVAR) or open repair of abdominal
aortic aneurysms in 2005-2007.
Fig 4. Surgical site infections by bodymass index classification for
patients undergoing endovascular (EVAR) or open repair of ab-
dominal aortic aneurysms in 2005-2007.an increased mortality in OAR (OR, 3.4; 95% CI, 1.6-7.4,P  .01). No deaths occurred in patients with postopera-
tive wound infections after EVAR. Wound infection was
associated with early graft failure after both OAR (OR,
12.9; 95% CI, 4.8-34.5; P  .001) and EVAR (OR, 7.3;
95% CI, 2.8-19.2; P  .001) as well as with return to the
operating room 30 days for OAR (OR, 9.0; 95% CI,
5.5-14.8, P  .001) and EVAR (OR, 6.3; 95% CI, 3.5-
11.5; P  .001).
Predictors of mortality. Multivariate predictors of
OAR mortality were increasing age, long-term steroid use,
peripheral vascular disease (PVD) with prior surgery or
intervention, cardiac disease, renal disease, and morbid
obesity (compared with normal weight and mildly over-
weight patients; Table II, A). In the male-only population,
morbid obesity carried a similar risk (OR, 2.6; P  .05).
Significant predictors of EVAR mortality were cardiac dis-
ease and female gender (Table II, B). Underweight BMI
classification nearly reached significance after adjustment
for other factors (OR, 3.5; P .052). In the subset of men
only, underweight patients had a similarly increased risk of
mortality (OR, 3.6; P  .05). Analyzing all AAA repairs
combined, predictors of mortality were open repair (OR,
3.7), increasing age (OR, 1.3), cardiac disease (OR, 2.0),
long-term steroid use (OR, 2.9), PVD (OR, 2.3), renal
disease (OR, 1.9), female gender (OR, 1.6), and morbid
obesity (OR, 2.2; P  .001).
Predictors of morbidity. Overall morbidity was pre-
dicted by OAR, increasing age, long-term steroid use, renal
disease, PVD, female gender, cardiac disease, and under-
Table II. Multivariate predictors of mortality after (A)
open and (B) endovascular AAA repair, NSQIP 2005-
2007
Type of repair OR 95% CI P
A, Open repair
Age (per decade) 1.3 1.2-1.6 .001
Long-term steroid use 3.9 1.7-9.0 .01
PVD with prior surgery 3.0 1.5-6.2 .01
Cardiac disease 2.0 1.2-3.2 .01
Renal disease 2.0 1.1-3.7 .05
Weight class by BMI (kg/m2)a
Underweight (18.6) 0.9 0.2-3.8 .85
Obese I (30-35) 1.0 0.6-1.9 .90
Obese II (35-40) 1.0 0.3-3.0 .88
Morbid obesity (40) 2.6 1.04-6.3 .05
B, Endovascular repair
Age (per decade) 1.2 0.99-1.5 .06
Female gender 2.7 14-5.4 .01
Cardiac disease 2.0 1.04-3.8 .05
Weight class by BMI (kg/m2)a
Underweight (18.6) 3.5 0.99-12.1 .052
Obese I (30-35) 1.3 0.6-3.0 .52
Obese II (35-40) 1.4 0.4-5.2 .50
Morbid obesity (40) 2.5 0.7-8.5 .13
AAA, abdominal aortic aneurysm; BMI, body mass index; CI, confidence
interval; NSQIP, National Surgical Quality Improvement Program; OR,
odds ratio; PVD, peripheral vascular disease.
aVs normal/overweight, defined as BMI of 18.6-30 kg/m2.weight classification (Table III).
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tors of postoperative surgical site infection were open re-
pair, chronic steroid use, female gender, and obesity (class
I, II, and morbid obesity; Table III). Morbid obesity was
associated with a greater than fivefold increased risk of
surgical site infection.
DISCUSSION
More 20% of the United States population is consid-
ered obese, and the rates are consistently increasing.1
Smaller studies of vascular procedures have not shown a
significant relationship with obesity andmortality.6,8 Infec-
tious complications, however, have been more reliably
linked to obesity.6,14 Stratification by BMI classification is
also an important and novel feature of the current analysis
for AAA repair outcomes.
This study demonstrates that perioperative mortality
for AAA repair varies by weight classification, with an
overall U-shaped distribution where patients at weight
extremes (underweight or morbidly obese) fare the worst.
The differences in statistical significance must be inter-
preted with caution, however, because few patients were at
the extremes of weight. Interestingly, EVAR has a lack of
mortality benefit compared with OAR for underweight
patients.
Mullen et al2 found an increased risk of death within
Table III. Multivariate predictors of (A) overall
morbidity and (B) surgical site infections after
endovascular and open abdominal aortic aneurysm repair,
NSQIP 2005-2007
Outcome OR 95% CI P
A, Morbidity
Age (per decade) 1.1 1.1-1.2 .001
Open repair 3.0 2.6-3.5 .001
Long-term steroid use 1.8 1.3-2.6 .001
Renal disease 1.5 1.2-1.9 .001
PVD with prior surgery 1.6 1.2-2.1 .01
Female gender 1.3 1.1-1.5 .01
Cardiac disease 1.2 1.04-1.4 .05
Weight class by BMI (kg/m2)a
Underweight (18.6) 1.9 1.3-2.8 .01
Obese I (30-35) 1.1 0.9-1.3 .46
Obese II (35-40) 1.2 0.9-1.6 .30
Morbid obesity (40) 1.2 0.8-1.7 .40
B, Surgical site infection
Age (per decade) 1.0 0.9-1.1 .47
Open repair 1.7 1.2-2.4 .01
Renal disease 1.9 1.2-3.0 .01
Long-term steroid use 2.0 1.01-3.9 .05
Female gender 1.6 1.01-2.2 .05
Weight class by BMI (kg/m2)a
Underweight (18.6) 0.7 0.2-3.0 .65
Obese I (30-35) 2.1 1.4-3.2 .001
Obese II (35-40) 2.0 1.1-3.8 .05
Morbid obesity (40) 5.2 3.1-8.8 .001
BMI, Body mass index; CI, confidence interval; NSQIP, National Surgical
Quality Improvement Program; OR, odds ratio; PVD, peripheral vascular
disease.
aVs normal/overweight, defined as BMI 18.6-30 kg/m2.underweight patients after surgical oncology procedures.Other BMI classes were not at an increased risk.2 Our
institution has previously shown that obesity was unrelated
to mortality after lower extremity bypass procedures.6
More recently, however, our analysis of the NSQIP data-
base showed a similar U-shaped distribution for mortality
after lower extremity bypass when patients are character-
ized by BMI classification rather than as a dichotomous
obesity variable.15 A European study looking at a decade of
elective and emergent vascular procedures, including AAA
repair, found that obesity was not associated with an in-
creased risk of mortality.14 Our analysis among open repair
patients found morbidly obese patients were at a 2.6-fold
higher risk of mortality. In contrast, for those undergoing
EVAR, underweight patients had a 3.5-fold increased risk
of mortality that was just shy of statistical significance.
There was a trend for morbidly obese patients undergoing
EVAR to also have an increased risk of death (OR, 2.5; P
.13). For the combined measure of all AAA repair, morbid
obesity remains a strong mortality predictor.
Johnson et al16 recently examined obesity-related out-
comes of 2000 AAA patients undergoing OAR and
EVAR from the Veterans Affairs NSQIP 2004 and 2005.
They found no difference in 30-day mortality between
overweight and normal-weight patients. The authors were
able to examine long-term outcomes and also found no
significant differences among weight classifications for
mortality at 2 years. However, the relative benefit of EVAR
compared with OAR was increased in obese patients, from
a 47% relative risk reduction compared with 18% in non-
obese patients. Their study group was 99% male, and the
underweight patients had to be excluded because only 0.3%
had a BMI18.5 kg/m2.16 Given these differences, there-
fore, it is difficult to draw comparisons to our current study
population. When we further examined our study popula-
tion excluding women, the conclusions were similar. How-
ever, further studies examining the role of gender in AAA
outcomes with obesity may be indicated as a result of these
two study findings. Medical comorbidities that were pre-
dictors of mortality in this study are consistent with prior
studies evaluating AAA repair.17-19
Overall morbidity after EVAR shows a U-shaped dis-
tribution among weight classes, whereas the highest mor-
bidity after OAR is in the underweight category and mor-
bidity in the other weight classes ranges from 26% to 31%.
Within general surgery operations, Mullen et al2 found an
increased risk of morbidity for obese class I and II patients
but not for underweight patients. Within the current study,
morbidity was most frequently respiratory or septic compli-
cations and return to the operating room. The exact indi-
cations for reoperation are not included within the data-
base, however, so conclusions derived from his information
are limited. The NSQIP definition for return to the oper-
ating room includes only “major” surgical procedures30
days. This definition may include a spectrum of procedure
magnitude from bowel operation for colonic ischemia to
endovascular reinterventions such as coil embolization for
an endoleak.
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EVAR but are associated with adverse outcomes for both
OAR and EVAR. Obesity (obese I, II, and morbid obesity)
is a risk factor for surgical site infection, and recognition of
this increased risk is important in the choice of repair
method and perioperative management. Infections were
associated with increased graft failure, subsequent major
operation, length of stay in OAR patients, and mortality.
Infections after EVAR were associated with increased graft
failure, subsequent operations, and length of stay, but not
mortality. It is likely that graft failure and subsequent
operation are responsible for the increased wound infection
rate rather than the converse; however, we cannot infer a
causal relationship with this data. Other studies have found
similar relationships between obesity and higher wound
complication rates.2,6,14
The NSQIP database is more robust than most admin-
istrative databases but still has a few notable limitations that
must be addressed. The database was designed as a tool for
quality control assessment so individual institutions could
compare their performance, in a risk adjusted manner, with
national benchmarks. As participation has grown, the data
set has changed rapidly to include not only academic cen-
ters but also community and rural hospitals. Information
regarding the characteristics of the represented population
within a given year is not readily available; therefore, ex-
trapolation of outcomes to the general United States pop-
ulation is difficult.
The database is also subject to reviewer error and
data miscoding and lacks certain details that are impor-
tant to AAA repair. We may not make conclusions re-
garding aneurysm size or suitability for EVAR in addi-
tion to paravisceral extension. We also cannot identify
symptomatic presentation other than ruptured AAAs.
We have no information detailing what procedures were
done for patients undergoing reoperations. Intensive
care unit length of stay and discharge destination, unfor-
tunately, are also not included in the data set.
CONCLUSIONS
BMI must be considered as a risk factor when plan-
ning aneurysm repair. Although underweight patients
have the highest mortality risk with EVAR, morbidly
obese patients have the highest mortality risk with OAR.
There is no mortality benefit with EVAR compared with
OAR for underweight patients, whereas morbidly obese
patients may be better suited for EVAR. In addition,
given the lower mortality, EVAR is being underused in
normal, overweight, and morbidly obese patients but is
being appropriately used more frequently than OAR in
mild and moderately obese patients. Surgical site infec-
tions, higher in all obese patients, were associated with
increased rates of death, graft failure, and subsequent
operation, making this an important relationship to con-
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